Psychedelics, mental health, COVID-19, and our drug laws: The Silent Pandemic and the search for innovation in the treatment of mental health problems. Please read this article by Beatrix Vas – and watch the movie they produced about research on psychedelics!
Levente Moro is a well-known member of the European psychedelic community. He earned his PhD in 2017 at the University of Turku, on the subject of hallucinatory altered states of consciousness. In 2012 he started PsyHelp, an organisation by partiers, for partiers, to make psytrance and Goa concerts and festivals safer. Read the interview made by our intern, Jonathan Brozdowski!
Drugreporter and Harm Reduction International co-organises the International Harm Reduction Film Festival next week in Porto, sponsored by Elton John AIDS Fund. There is an incredibly strong selection of movies – browse the programme and watch some trailers below!
Inspired by the testimony of a psychedelic fungi grower, we went to the Czech National Mental Health Institute in the Czech Republic to meet the scientists making psychedelics legal. A movie produced by Polish members of our global video advocacy network.
A new education video series, a training for activists in Bangkok, filming the Canadian drug policy conference and advocacy at the EU Civil Society Forum on Drugs – 2018 was an eventful year in the life of the Rights Reporter Foundation and its drug policy website, Drugreporter. Please explore our activities in our new annual report!
You can either download the report by clicking on this link, or you can read it online with ISUU below!
The Rights Reporter Foundation and Harm Reduction International welcomes entries to the Film Festival at the 26th Harm Reduction International Conference! The deadline is extended to March 13, 2019 (11:59 pm CET)
How does the first wave of psychedelic research and science from the 1940s and 50s compare to what is ongoing today worldwide? 2017 saw the biggest international psychedelic conference that has ever taken place. Watch the video produced by the Mexican members of our global video network!
Hallucinogens are known to affect cognition, perception and emotions; we still, however, know little about how these drugs produce their mind-altering effects. Hallucinogenic action is thought to occur by binding and activating a subtype of serotonin receptor, called the 2A. In this edition of Dose of Science, we look at a recent paper which demonstrates the role of this receptor during psychedelic experiences.
A psychedelic renaissance is happening right now; but before classic hallucinogenic drugs can be accepted into mainstream medicine, their safety must be demonstrated. To move towards this goal, Norwegian scientists published a study claiming that psychedelics are not linked to long-term mental health problems; these findings, however, were quickly challenged. Dose of Science takes a look at the debate.
This movie is featuring the Global Ibogaine Conference that was held in Mexico in March, filmed by a member of Drugreporter’s new global video network and an alumni of our video advocacy training, Brun Balanced and his peers, Karina Muscarina and Gabriel Amezcua.